Journal of Antimicrobial Chemotherapy (1999) 44, 675-678
© 1999 The British Society for Antimicrobial Chemotherapy
Brief report |
Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus
a Bristol Centre for Antimicrobial Research and Evaluation, Southmead Health Services NHS Trust and University of Bristol, Department of Microbiology, Southmead Hospital, Bristol BS10 5NB b Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK
Isolates of Staphylococcus aureus resistant to vancomycin have been reported but appear to be extremely rare. However, isolates displaying hetero-resistance to vancomycin (hVRSA) are reportedly common in parts of Japan (9.3% of MRSA isolated from a group of university hospitals). We have investigated the reliability of the proposed method for detection of hetero-resistant isolates and the ability of clinical S. aureus isolates to express vancomycin resistance. The original method for identification of hVRSA was found to have poor reproducibility and may select for, rather than detect, vancomycin resistance. There appears to be a spectrum of heterogeneity in the expression of resistance to vancomycin among S. aureus. Until there is a clearer understanding of the mechanism and control of vancomycin resistance in S. aureus, and reliable tests are devised, the clinical relevance of different degrees of hetero-resistance cannot be assessed.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Sancak, S. Ercis, D. Menemenlioglu, S. Colakoglu, and G. Hascelik Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital J. Antimicrob. Chemother., September 1, 2005; 56(3): 519 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu and H. F. Chambers Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3040 - 3045. [Full Text] [PDF] |
||||
![]() |
H. B. Kim, W. B. Park, K. D. Lee, Y. J. Choi, S. W. Park, M.-d. Oh, E.-C. Kim, and K. W. Choe Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea J. Clin. Microbiol., June 1, 2003; 41(6): 2279 - 2281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-N. Kim, S. H. Hwang, Y.-J. Pyo, H.-M. Mun, and C. H. Pai Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea J. Clin. Microbiol., April 1, 2002; 40(4): 1376 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Silverman, N. Oliver, T. Andrew, and T. Li Resistance Studies with Daptomycin Antimicrob. Agents Chemother., June 1, 2001; 45(6): 1799 - 1802. [Abstract] [Full Text] |
||||
![]() |
M. Wootton, R. A. Howe, R. Hillman, T. R. Walsh, P. M. Bennett, and A. P. MacGowan A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital J. Antimicrob. Chemother., April 1, 2001; 47(4): 399 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vaudaux, P. Francois, B. Berger-Bachi, and D. P. Lew In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus J. Antimicrob. Chemother., February 1, 2001; 47(2): 163 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Francis, D. Joh, C. Bellinger-Kawahara, M. J. Hawkinson, T. F. Purchio, and P. R. Contag Monitoring Bioluminescent Staphylococcus aureus Infections in Living Mice Using a Novel luxABCDE Construct Infect. Immun., June 1, 2000; 68(6): 3594 - 3600. [Abstract] [Full Text] [PDF] |
||||



